Opportunity Information: Apply for RFA DE 20 001
The National Institutes of Health (NIH) released this discretionary grant funding opportunity, RFA-DE-20-001, titled "Oral Health in People Living with HIV and Additional Non-Communicable Diseases (R01 Clinical Trial Not Allowed)," to push forward research that clarifies what is happening in the mouths and overall oral health of people living with HIV (PLWH), especially those who are also dealing with non-communicable diseases (NCDs). The main idea is that as HIV has increasingly become a manageable chronic condition for many people because of antiretroviral therapy (ART), a growing share of PLWH are also living longer and facing other chronic health issues like cardiovascular disease, diabetes, kidney disease, and other NCDs. This FOA is aimed at filling major knowledge gaps about how HIV infection itself, long-term ART exposure, and the presence of NCDs interact to shape oral disease risk, severity, progression, and outcomes.
A central focus of the opportunity is understanding the combined and overlapping effects of HIV, ART, and NCDs on oral health status. In practical terms, that means research that can untangle whether certain oral conditions in PLWH are driven primarily by immune changes associated with HIV, by medication effects (such as changes in saliva, inflammation, or metabolism), by comorbid chronic diseases, or by the way these factors compound each other. The FOA encourages work that goes beyond describing oral disease prevalence and instead produces clearer evidence about mechanisms, risk profiles, and clinically meaningful patterns that could influence dental care planning for PLWH who may have complex medical histories.
The announcement also emphasizes the need to identify better approaches for prevention and treatment of oral diseases in PLWH, and it supports assessment of treatment outcomes in PLWH with or without additional NCDs. This includes research that examines how well specific dental and oral health interventions work in these populations, what factors predict better or worse outcomes, and how comorbid conditions may require adapted management strategies. A key expected contribution is evidence that can support the development or refinement of oral health treatment guidelines tailored to dental patients with HIV, recognizing that standard approaches used for the general population may not fully address the clinical realities of HIV and multimorbidity.
This is an R01 mechanism, meaning it is intended for substantial, hypothesis-driven research projects, and it is explicitly labeled "Clinical Trial Not Allowed," which signals that applications should not propose a clinical trial as defined by NIH standards. In general, that steers applicants toward observational, epidemiologic, behavioral, translational, or other non-trial study designs that still produce rigorous evidence on oral health outcomes, determinants, and care considerations for PLWH, including those with NCD comorbidities.
Eligibility is broad and includes a wide range of organizational types that can contribute to this research area. Eligible applicants include state, county, city or township governments, special district governments, and independent school districts; public and state-controlled institutions of higher education and private institutions of higher education; federally recognized Native American tribal governments as well as tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (excluding institutions of higher education in those categories); for-profit organizations other than small businesses, as well as small businesses; and other organizations that meet NIH eligibility requirements. The FOA also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, non-U.S. entities (foreign organizations), regional organizations, Indian/Native American tribal governments that are not federally recognized, and U.S. territories or possessions. This broad eligibility reflects the reality that meaningful research in this space often benefits from partnerships among academic centers, community organizations, safety-net providers, and institutions serving populations disproportionately affected by HIV and chronic diseases.
From an administrative standpoint, the opportunity is classified under the health funding activity category and is associated with CFDA number 93.121. The FOA was created on April 8, 2019, and the original closing date listed is July 29, 2019. The notice does not provide an award ceiling or an expected number of awards in the excerpt provided, which typically means applicants would need to consult the full FOA text and NIH budget guidance for details on allowable budget levels, project periods, and anticipated funding volume. Overall, the opportunity is designed to generate stronger, more practical evidence about oral health needs and management in PLWH, particularly in the increasingly common context of HIV combined with additional chronic non-communicable diseases.Apply for RFA DE 20 001
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Oral Health in People Living with HIV and Additional Non-Communicable Diseases (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121.
- This funding opportunity was created on 2019-04-08.
- Applicants must submit their applications by 2019-07-29. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: ADDENDUM-3-BAA-OAA-LLDI-2019
Previous opportunity: Establishing a Cohort to Clarify Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) - Planning Cooperative Agreements (U34 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DE 20 001
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DE 20 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| International Bioethics Research Training Program (D43 Clinical Trial Optional) Apply for PAR 19 243 Funding Number: PAR 19 243 Agency: National Institutes of Health Category: Health Funding Amount: $230,000 |
| Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R21 Clinical Trial Not Allowed) Apply for PAR 19 247 Funding Number: PAR 19 247 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R01 Clinical Trial Not Allowed) Apply for PAR 19 248 Funding Number: PAR 19 248 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 030 Funding Number: RFA AI 19 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Focused Technology Research and Development (R01 - Clinical Trial Not Allowed) Apply for PAR 19 253 Funding Number: PAR 19 253 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Exploratory Research for Technology Development (R21 - Clinical Trial Not Allowed) Apply for PAR 19 254 Funding Number: PAR 19 254 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03) Apply for PAR 19 257 Funding Number: PAR 19 257 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Trusted Exchange Framework and Common Agreement - Recognized Coordinating Entity (RCE) Cooperative Agreement Apply for NAP AX 19 001 Funding Number: NAP AX 19 001 Agency: Office of the National Coordinator Category: Health Funding Amount: $900,000 |
| MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health Services, Voluntary Family Planning, and Reproductive Health Care [MNCH/FP/RH] to Scale) Apply for 7200AA19APS00002 Funding Number: 7200AA19APS00002 Agency: Agency for International Development Category: Health Funding Amount: $500,000,000 |
| NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) Apply for PAR 19 260 Funding Number: PAR 19 260 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) Apply for RFA AR 20 001 Funding Number: RFA AR 20 001 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) Apply for RFA AR 20 002 Funding Number: RFA AR 20 002 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43 - Clinical Trial Not Allowed) Apply for RFA AR 20 003 Funding Number: RFA AR 20 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| "HEAL Initiative: Limited Competition: Resource Coordinating Center for Pragmatic and Implementation Studies for the Management of Pain (PRISM) to Reduce Opioid Prescribing (U24 Clinical Trial Not Allowed)" Apply for RFA AT 19 011 Funding Number: RFA AT 19 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV/AIDS Clinical Trials Units (UM1 Clinical Trial Required) Apply for RFA AI 19 045 Funding Number: RFA AI 19 045 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HLA and KIR Region Genomics in Immune-Mediated Diseases (U19 Clinical Trial Not Allowed) Apply for RFA AI 19 044 Funding Number: RFA AI 19 044 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed) Apply for PAR 19 266 Funding Number: PAR 19 266 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed) Apply for PAR 19 265 Funding Number: PAR 19 265 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed) Apply for PAR 19 268 Funding Number: PAR 19 268 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Medicare Model Guidelines, Version 8 Apply for CMS 1C0 19 001 Funding Number: CMS 1C0 19 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $100,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DE 20 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
